Cantel Medical Corp.

80.37-0.9600-1.18%Vol 11.82M1Y Perf 85.44%
Jun 1st, 2021 18:40 DELAYED
BID0.0000 ASK123.00
Open81.54 Previous Close81.33
Pre-Market- After-Market-
 - -%  - -
Target Price
66.00 
Analyst Rating
Moderate Buy 2.25
Potential %
- 
Finscreener Ranking
★+ —    -
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★★ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
0.00 
Earnings Rating
Neutral
Market Cap3.58B 
Earnings Date
3rd Jun 2021
Alpha Standard Deviation
Beta 

Today's Price Range

80.3781.74

52W Range

39.4089.76

5 Year PE Ratio Range

15.8076.60

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-
1 Month
-
3 Months
0.00%
6 Months
2.64%
1 Year
85.44%
3 Years
-16.82%
5 Years
112.62%
10 Years
68.84%

TickerPriceChg.Chg.%
CMD80.37-0.9600-1.18
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Financial StrengthValueIndustryS&P 500US Markets
1.70
2.60
0.53
1.15
2.10
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
47.40
11.50
18.70
10.10
4.69
RevenueValueIndustryS&P 500US Markets
1.14B
26.90
8.46
10.60
DividendsValueIndustryS&P 500US Markets
0.27
0.21
-9.56
3.15
Payout ratio14.00
Earnings HistoryEstimateReportedSurprise %
Q02 20210.490.7961.22
Q01 20210.360.90150.00
Q04 20200.080.24200.00
Q03 20200.140.1614.29
Q02 20200.680.61-10.29
Q01 20200.570.6514.04
Q04 20190.610.633.28
Q03 20190.550.550.00
Earnings Per EndEstimateRevision %Trend
4/2021 QR0.6522.64Positive
7/2021 QR0.724.35Positive
7/2021 FY2.62394.34Positive
7/2022 FY2.78302.90Positive
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %19.00
Volume Overview
Volume11.82M
Shares Outstanding44.51M
Shares Float0
Trades Count4.98K
Dollar Volume44.43M
Avg. Volume626.60K
Avg. Weekly Volume2.88M
Avg. Monthly Volume997.03K
Avg. Quarterly Volume637.31K

Cantel Medical Corp. (NYSE: CMD) stock closed at 80.37 per share at the end of the most recent trading day (a -1.18% change compared to the prior day closing price) with a volume of 11.82M shares and market capitalization of 3.58B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3669 people. Cantel Medical Corp. CEO is George L. Fotiades.

The one-year performance of Cantel Medical Corp. stock is 85.44%, while year-to-date (YTD) performance is 1.91%. CMD stock has a five-year performance of 112.62%. Its 52-week range is between 39.4 and 89.76, which gives CMD stock a 52-week price range ratio of %

Cantel Medical Corp. currently has a PE ratio of 68.70, a price-to-book (PB) ratio of 4.16, a price-to-sale (PS) ratio of 2.99, a price to cashflow ratio of 18.60, a PEG ratio of 2.32, a ROA of 2.52%, a ROC of 5.67% and a ROE of 6.62%. The company’s profit margin is 4.69%, its EBITDA margin is 18.70%, and its revenue ttm is $1.14 Billion , which makes it $26.90 revenue per share.

Of the last four earnings reports from Cantel Medical Corp., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Cantel Medical Corp.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Cantel Medical Corp. is Moderate Buy (2.25), with a target price of $66, which is 0.00% compared to the current price. The earnings rating for Cantel Medical Corp. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cantel Medical Corp. has a dividend yield of 0.27% with a dividend per share of $0.21 and a payout ratio of 14.00%.

Cantel Medical Corp. has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.01, ATR14 : 1.37, CCI20 : 66.67, Chaikin Money Flow : -1.00, MACD : -0.43, Money Flow Index : 0.00, ROC : 0.00, RSI : 33.35, STOCH (14,3) : 0.00, STOCH RSI : 1.00, UO : 1.30, Williams %R : -100.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cantel Medical Corp. in the last 12-months were: Ann E. Berman (Sold 5 500 shares of value $453 255 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.25
Moderate Buy
2.25
Moderate Buy
2.25

Cantel Medical Corp.

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.

CEO: George L. Fotiades

Telephone: +1 973 890-7220

Address: 150 Clove Road, Little Falls 07424, NJ, US

Number of employees: 3 669

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

55%45%

News

Stocktwits